In vivo NMR imaging evaluation of efficiency and toxicity of gene electrotransfer in rat muscle

Gene Therapy

Volumn 12, Issue 19, 2005, Pages 1434-1443

  Leroy Willig, A ^a   Bureau, M F ^b   Scherman, D ^b   Carlier, P G ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CNRS   (France)

Author keywords

Contrast agent; Electrotransfer; Magnetic resonance; MRI; Muscle

Indexed keywords

CONTRAST MEDIUM; GADOTERIC ACID; LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRIC CONDUCTIVITY; ELECTRIC FIELD; ELECTROPORATION; GENE TARGETING; IMAGE ANALYSIS; IN VIVO STUDY; LIGHT INTENSITY; MALE; MUSCLE NECROSIS; MUSCLE RELAXATION; NONHUMAN; NONVIRAL GENE THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; THREE DIMENSIONAL IMAGING; TIBIALIS ANTERIOR MUSCLE;

ANIMALS; CONTRAST MEDIA; ELECTROPORATION; GENE EXPRESSION; GENE THERAPY; HETEROCYCLIC COMPOUNDS; INJECTIONS, INTRAMUSCULAR; LUCIFERASES; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; ORGANOMETALLIC COMPOUNDS; PLASMIDS; RATS; RATS, WISTAR;

EID: 27144472942     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302541     Document Type: Article

References (39)

1. Bloquel C, Fabre E, Bureau MF, Scherman D. Plasmid DNA electrotransfer for intracellular and secreted proteins expression: New methodological developments and applications. J Gene Med 2004; 6 (Suppl 1 : S11-S23.
2. Rizzuto G et al. Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. Hum Gene Ther 2000; 11: 1891-1900.
3. Bloquel C et al. Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-alpha soluble receptor I variants. Hum Gene Ther 2004; 15: 189-201.
4. Silvestre JS et al. Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ Res 2000; 87: 448-452.
5. Watanabe K et al. Protection against autoimmune myocarditis by gene transfer of interleukin-10 by electroporation. Circulation 2001; 104: 1098-1100.
6. Rols MP et al. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 1998; 16: 168-171.
7. Gehl J. Electroporation: Theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 2003; 177: 437-447.
8. Vilquin JT et al. Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies. Gene Therapy 2001; 8: 1097-1107.
9. Widera G et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 2000; 164: 4635-4640.
10. Mir LM. Therapeutic perspectives of in vivo cell electropermeabilization. Bioelectrochemistry 2001; 53: 1-10.
11. Mir LM et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 1999; 96 4262-4267.
12. Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867-870.
13. Mathiesen I. Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Therapy 1999; 6: 508-514.
14. Vicat JM et al. Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expression. Hum Gene Ther 2000; 11: 909-916.
15. Durieux AC, Bonnefoy R, Manissolle C, Freyssenet D. High-efficiency gene electrotransfer into skeletal muscle: Description and physiological applicability of a new pulse generator. Biochem Biophys Res Commun 2002; 296: 443-450.
16. Umeda Y et al. Skeletal muscle targeting in vivo electroporation-mediated HGF gene therapy of bleomycin-induced pulmonary fibrosis in mice. Lab Invest 2004; 84: 836-844.
17. Payen E et al. Improvement of mouse beta-thalassemia by electrotransfer of erythropoietin cDNA. Exp Hematol 2001; 29 295-300.
18. Gehl J et al. In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta 1999; 1428: 233-240.
19. Mir LM, Banoun H, Paoletti C. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp Cell Res 1988; 175: 15-25.
20. Hartikka J et al. Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: Plasmid dependence of muscle damage and effect of poloxamer 188. Mol Ther 2001; 4: 407-415.
21. Paturneau-Jouas M et al. Electrotransfer at MR imaging: Tool for optimization of gene transfer protocols - feasibility study in mice. Radiology 2003; 228: 768-775.
22. Rinck P. Magnetic Resonance in Medicine: The Basic Textbook of the European Magnetic Resonance Forum, 4th edn. Blackwell Science: Berlin, Germany, 2001.
23. Wishnia A, Alameddine H, Tardif de Gery S, Leroy-Willig A. Use of magnetic resonance imaging for noninvasive characterization and follow-up of an experimental injury to normal mouse muscles. Neuromuscul Disord 2001; 11: 50-55.
24. Ni Y et al. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis. Invest Radiol 1997; 32: 770-779.
25. Mathur-de-Vré R, Lemort M. Biophysical properties and clinical applications of magnetic resonance imaging contrast agents. Br J Radiol 1995; 68: 225-247.
26. Rozijn TH et al. Determination of in vivo rat muscle Gd-DTPA relaxivity at 6.3 T. Magma 1999; 9: 65-71.
27. Crich S et al. Relaxation efficiency of cell internalized Gd-HPDO3A ESMRMB 21th Annual Meeting, Copenhagen, September 8-12, 2004, p S222.
28. Gehl J, Mir LM. Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem Biophys Res Commun 1999; 261: 377-380.
29. Paturneau-Jouas M et al. Electroporation-mediated delivery of a magnetic resonance imaging contrast agent into muscle to visualize electrotransfer. Acta Myologica 2001; 20: 174-178.
30. Van Donkelaar CC et al. Diffusion tensor imaging in biomechanical studies of skeletal muscle function. J Anat 1999; 194: 79-88.
31. Wishnia A, Alameddine H, Tardif de Géry S, Leroy-Willig A. Use of magnetic resonance imaging for noninvasive characterisation and follow-up of experimental injury to normal mouse muscle. Neuromusc Disord 2001; 11: 50-55.
32. Ferret E, Evrard C, Foucal A, Gervais P. Volume changes of isolated human K562 leukemia cells induced by electric field pulses. Biotechnol Bioeng 2000; 67: 520-528.
33. Bureau MF et al. Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta 2000; 1474: 353-359.
34. Allamand V et al. Early adenovirus-mediated gene transfer effectively prevents muscular dystrophy in alpha-sarcoglycan-deficient mice. Gene Therapy 2000; 7: 1385-1391.
35. Palasz A, Czekaj P. Toxicological and cytophysiological aspects of lanthanides action. Acta Biochim Pol 2000; 47: 1107-1114.
36. Crich SG et al. Improved route for the visualization of stem cells labeled with a Gd-/Eu-chelate as dual (MRI and fluorescence) agent. Magn Reson Med 2004; 51: 938-944.
37. Bell JD, Taylor-Robinson SD. Assessing gene expression in vivo: magnetic resonance imaging and spectroscopy. Gene Therapy 2000; 7: 1259-1264.
38. Soubrier F et al. pCOR: A new design of plasmid vectors for nonviral gene therapy. Gene Therapy 1999; 6: 1482-1488.
39. Brasch RC. Rationale and applications for macromolecular Gd-based contrast agents. Magn Reson Med 1991; 22: 282-287.